Reneo Pharmaceuticals Inc. (RPHM) NASDAQ
$6.55 0.21 (3.31%)
Market Cap: $218.19M
As of 12/01/23 04:00 PM EST. Market closed.
Reneo Pharmaceuticals Inc. (RPHM)
NASDAQ
$6.55
0.21 (3.31%)
Market Cap: $218.19M
As of 12/01/23 04:00 PM EST. Market closed.
Add to Portfolio
reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. many of these diseases are associated with deficits in cellular metabolism and energy production. our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, ... read more
reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. many of these diseases are associated with deficits in cellular metabolism and energy production. our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness and wasting. we are currently advancing a novel molecule into several diseases. our experienced team of drug development experts, who have collaborated in many successful programs, are dedicated and passionate about finding effective therapies for these complex rare diseases. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Address
.
PRICE CHART FOR RENEO PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.29
Previous Close
$6.34
Days Range
$6.32 - $6.75
52 week range
$1.79 - $11.30
Volume
761,629
Avg. Volume (30 days)
218,839
Market Cap
$218.19M
Dividend Yield
-
P/E
-
Shares Outstanding
33,311,787
Open
$6.29
Previous Close
$6.34
Days Range
$6.32 - $6.75
52 week range
$1.79 - $11.30
Volume
761,629
Avg. Volume (30 days)
218,839
Market Cap
$218.19M
Dividend Yield
-
P/E
-
Shares Outstanding
33,311,787
FINANCIAL STATEMENTS FOR RENEO PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR RENEO PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Hall Ashley | Chief Development Officer | Aug 28, 2023 | Option Exercise | $1.80 | 15,625 | 28,125 | 55,225 | Aug 29, 2023, 05:04 PM |
| Hall Ashley | Chief Development Officer | Aug 28, 2023 | Sale | $6.28 | 15,625 | 98,058 | 39,600 | Aug 29, 2023, 05:04 PM |
| Novo Holdings A/S | 10% Owner | Jun 23, 2023 | Sale | $7.10 | 100,000 | 709,740 | 3,330,337 | Jun 23, 2023, 07:15 PM |
| O'Donnell Niall | Director | May 08, 2023 | Buy | $8.00 | 125,000 | 1,000,000 | 2,188,713 | May 10, 2023, 05:47 PM |
| Cruse Michael | Chief Operating Officer | Sep 01, 2022 | Buy | $3.39 | 7,500 | 25,447 | 13,697 | Sep 02, 2022, 05:12 PM |
| GREY MICHAEL G | Executive Chairman | Aug 31, 2022 | Option Exercise | $1.97 | 50,000 | 98,500 | 50,000 | Sep 02, 2022, 05:10 PM |
| Cruse Michael | Chief Operating Officer | Aug 29, 2022 | Buy | $3.24 | 1,140 | 3,694 | 1,140 | Aug 31, 2022, 05:47 PM |
| Cruse Michael | Chief Operating Officer | Aug 29, 2022 | Buy | $3.24 | 83 | 269 | 30,783 | Aug 31, 2022, 05:47 PM |
| Cruse Michael | Chief Operating Officer | Aug 31, 2022 | Buy | $3.21 | 3,212 | 10,307 | 6,197 | Aug 31, 2022, 05:47 PM |
| Cruse Michael | Chief Operating Officer | Aug 30, 2022 | Buy | $3.19 | 1,845 | 5,893 | 2,985 | Aug 31, 2022, 05:47 PM |
| Cruse Michael | Chief Operating Officer | Aug 30, 2022 | Buy | $3.16 | 975 | 3,081 | 31,758 | Aug 31, 2022, 05:47 PM |
| Jindal Vineet R. | Chief Financial Officer | Aug 25, 2021 | Buy | $7.44 | 5,000 | 37,176 | 5,000 | Aug 26, 2021, 05:54 PM |
| FLESHER GREGORY J. | President and CEO | Aug 25, 2021 | Buy | $8.00 | 8,000 | 64,000 | 8,000 | Aug 26, 2021, 05:52 PM |
| Cruse Michael | Senior VP-Corporate Operations | Aug 25, 2021 | Buy | $7.45 | 2,500 | 18,616 | 2,500 | Aug 26, 2021, 05:51 PM |
| Muralidhar Bali | Director | Jul 14, 2021 | Buy | $8.50 | 111,736 | 949,756 | 2,073,957 | Jul 15, 2021, 05:34 PM |
| Johnson Wendy S. | Chief Development Officer | Jul 14, 2021 | Sale | $8.50 | 111,736 | 949,756 | 0 | Jul 15, 2021, 05:33 PM |
| Johnson Wendy S. | Chief Development Officer | Jul 08, 2021 | Option Exercise | $1.97 | 111,736 | 220,120 | 111,736 | Jul 09, 2021, 06:52 PM |
| Muralidhar Bali | Director | Jun 22, 2021 | Buy | $8.72 | 14,615 | 127,487 | 1,941,511 | Jun 23, 2021, 08:33 AM |
| Muralidhar Bali | Director | Jun 21, 2021 | Buy | $9.03 | 32,659 | 294,927 | 1,926,896 | Jun 23, 2021, 08:33 AM |
| Muralidhar Bali | Director | Jun 08, 2021 | Buy | $9.50 | 16,605 | 157,709 | 1,894,237 | Jun 10, 2021, 09:00 AM |
| Muralidhar Bali | Director | Jun 04, 2021 | Buy | $9.42 | 257 | 2,422 | 1,877,632 | Jun 07, 2021, 08:53 AM |
| Muralidhar Bali | Director | Jun 03, 2021 | Buy | $9.25 | 12,100 | 111,943 | 1,877,375 | Jun 07, 2021, 08:53 AM |
| Muralidhar Bali | Director | May 28, 2021 | Buy | $9.50 | 14 | 133 | 1,865,275 | Jun 02, 2021, 10:37 AM |
| Muralidhar Bali | Director | May 27, 2021 | Buy | $9.26 | 1,120 | 10,369 | 1,865,261 | May 28, 2021, 04:10 PM |
| Muralidhar Bali | Director | May 26, 2021 | Buy | $9.38 | 5,915 | 55,495 | 1,864,141 | May 28, 2021, 04:10 PM |
| New Enterprise Associates 15, L.P. | 10% Owner | Apr 13, 2021 | Buy | $15.00 | 666,666 | 9,999,990 | 4,785,494 | Apr 15, 2021, 06:16 PM |
| O'Donnell Niall | Director | Apr 13, 2021 | Buy | $15.00 | 200,000 | 3,000,000 | 2,063,713 | Apr 15, 2021, 04:16 PM |
| Muralidhar Bali | Director | Apr 13, 2021 | Buy | $15.00 | 200,000 | 3,000,000 | 1,858,226 | Apr 15, 2021, 04:15 PM |
| Novo Holdings A/S | 10% Owner | Apr 13, 2021 | Buy | $15.00 | 666,666 | 9,999,990 | 3,430,377 | Apr 14, 2021, 04:44 PM |
| RiverVest Venture Fund III, L.P. | 10% Owner | Apr 09, 2021 | Buy | $15.00 | 200,000 | 3,000,000 | 2,409,220 | Apr 13, 2021, 05:54 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Hall Ashley | Chief Development Officer | 08/28/2023 | 28,125 |
| Hall Ashley | Chief Development Officer | 08/28/2023 | 98,058 |
| Novo Holdings A/S | 10% Owner | 06/23/2023 | 709,740 |
| O'Donnell Niall | Director | 05/08/2023 | 1,000,000 |
| Cruse Michael | Chief Operating Officer | 09/01/2022 | 25,447 |
| GREY MICHAEL G | Executive Chairman | 08/31/2022 | 98,500 |
| Cruse Michael | Chief Operating Officer | 08/29/2022 | 3,694 |
| Cruse Michael | Chief Operating Officer | 08/29/2022 | 269 |
| Cruse Michael | Chief Operating Officer | 08/31/2022 | 10,307 |
| Cruse Michael | Chief Operating Officer | 08/30/2022 | 5,893 |
| Cruse Michael | Chief Operating Officer | 08/30/2022 | 3,081 |
| Jindal Vineet R. | Chief Financial Officer | 08/25/2021 | 37,176 |
| FLESHER GREGORY J. | President and CEO | 08/25/2021 | 64,000 |
| Cruse Michael | Senior VP-Corporate Operations | 08/25/2021 | 18,616 |
| Muralidhar Bali | Director | 07/14/2021 | 949,756 |
| Johnson Wendy S. | Chief Development Officer | 07/14/2021 | 949,756 |
| Johnson Wendy S. | Chief Development Officer | 07/08/2021 | 220,120 |
| Muralidhar Bali | Director | 06/22/2021 | 127,487 |
| Muralidhar Bali | Director | 06/21/2021 | 294,927 |
| Muralidhar Bali | Director | 06/08/2021 | 157,709 |
| Muralidhar Bali | Director | 06/04/2021 | 2,422 |
| Muralidhar Bali | Director | 06/03/2021 | 111,943 |
| Muralidhar Bali | Director | 05/28/2021 | 133 |
| Muralidhar Bali | Director | 05/27/2021 | 10,369 |
| Muralidhar Bali | Director | 05/26/2021 | 55,495 |
| New Enterprise Associates 15, L.P. | 10% Owner | 04/13/2021 | 9,999,990 |
| O'Donnell Niall | Director | 04/13/2021 | 3,000,000 |
| Muralidhar Bali | Director | 04/13/2021 | 3,000,000 |
| Novo Holdings A/S | 10% Owner | 04/13/2021 | 9,999,990 |
| RiverVest Venture Fund III, L.P. | 10% Owner | 04/09/2021 | 3,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN RENEO PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 618,820 | 0.00014% | 35.43% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 330,629 | 0.0003% | 12.28% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 65,000 | 0.00112% | New | Other |
| RENAISSANCE TECHNOLOGIES LLC | 36,000 | 0.00047% | -41.09% | Other |
CHANGE IN SHARES OUTSTANDING FOR RENEO PHARMACEUTICALS INC
STOCK BUYBACKS FOR RENEO PHARMACEUTICALS INC
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
11.89%
1Q
12/31/2022
37.62%
3Q
09/30/2022
38.01%
4Q
06/30/2022
38.20%
5Q
03/31/2022
38.23%
6Q
09/30/2021
38.58%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR RENEO PHARMACEUTICALS INC
LOADING...